A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A∗0201 transgenic mice: implications for HTLV-1 vaccine design-Reference-Cited by-同舟云学术

A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A∗0201 transgenic mice: implications for HTLV-1 vaccine design

Published:2003-06 Issue:21-22 Volume:21 Page:2767-2781
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Sundaram Roshni,Sun Yiping,Walker Christopher M.,Lemonnier Francois A.,Jacobson Steven,Kaumaya Pravin T.P.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference57 articles.

1. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma;Poiesz;Proc. Natl. Acad. Sci. U.S.A.,1980

2. DNA plasmid based vaccination against the oncogenic human T cell leukemia virus type 1;Agadjanyan;Curr. Top. Microbiol. Immunol.,1998

3. Design of experimental synthetic peptide immunogens for prevention of HIV-1 and HTLV-1 retroviral infections;Hart;Pharm. Biotechnol.,1995

4. HTLV-1 associated myelopathy, a new clinical entity;Osame;Lancet,1986

5. Greten TF, Slansky JE, Kubota R., et al. Direct visualization of antigen-specific T cells: HTLV-1 Tax11–19-specific CD8+ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci USA 1998;95(13):7568–73.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HTLV-1 vaccination Landscape: Current developments and challenges;Vaccine: X;2024-08

2. Novel insights into human T‐lymphotropic virus type‐1 (HTLV‐1) pathogenesis‐host interactions in the manifestation of HTLV‐1‐associated myelopathy/tropical spastic paraparesis;Reviews in Medical Virology;2024-06-27

3. Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies;BMC Infectious Diseases;2023-05-11

4. Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years;Frontiers in Immunology;2023-02-13

5. Selective APC-targeting of a novel Fc-fusion multi-immunodominant recombinant protein (tTax-tEnv:mFcγ2a) for HTLV-1 vaccine development;Life Sciences;2022-11